Suppr超能文献

半乳糖密度对去唾液酸糖蛋白受体介导的半乳糖基化脂质体摄取的影响。

Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.

作者信息

Managit Chittima, Kawakami Shigeru, Yamashita Fumiyoshi, Hashida Mitsuru

机构信息

Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.

出版信息

J Pharm Sci. 2005 Oct;94(10):2266-75. doi: 10.1002/jps.20443.

Abstract

Galactosylated (Gal) liposomes containing various molar ratios of cholesten-5-yloxy-N-(4-((1-imino-2-D-thiogalactosylethyl)formamide (Gal-C4-Chol) as a ligand for asialoglycoprotein receptors were prepared to study the effect of the galactose content of Gal-liposomes labeled with [3H]cholesteryl hexadecyl ether on their targeted delivery to hepatocytes. The uptake characteristics of Gal-liposomes having Gal-C4-Chol of 1.0%, 2.5%, 3.5%, 5.0%, and 7.5% were evaluated. The uptake and internalization by HepG2 cells was enhanced by the addition of Gal-C4-Chol to the Gal-liposomes. In the presence of excess galactose, the uptake of Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5% was inhibited suggesting asialoglycoprotein receptor mediated uptake. After intravenous injection, Gal-liposomes having Gal-C4-Chol of 3.5%, 5.0%, and 7.5%, rapidly disappeared from the blood and exhibited rapid liver accumulation with up to about 80% of the dose within 10 min whereas Gal-liposomes having low Gal-C4-Chol (1.0% and 2.5%) showed a slight improvement in liver accumulation compared with bare-liposomes. Gal-liposomes with high Gal-C4-Chol are preferentially taken up by hepatocytes and the highest uptake ratio by parenchymal cells (PC) and nonparenchymal cells (NPC) (PC/NPC ratio) was observed with Gal-liposomes having of 5.0% Gal-C4-Chol. We report here that the galactose density of Gal-liposomes prepared by Gal-C4-Chol is important for both effective recognition by asialoglycoprotein receptors and cell internalization.

摘要

制备了含有不同摩尔比的胆甾-5-基氧基-N-(4-((1-亚氨基-2-D-硫代半乳糖基乙基)甲酰胺)(Gal-C4-Chol)作为去唾液酸糖蛋白受体配体的半乳糖基化(Gal)脂质体,以研究用[3H]胆固醇十六烷基醚标记的Gal-脂质体中半乳糖含量对其向肝细胞靶向递送的影响。评估了Gal-C4-Chol含量分别为1.0%、2.5%、3.5%、5.0%和7.5%的Gal-脂质体的摄取特性。向Gal-脂质体中添加Gal-C4-Chol可增强HepG2细胞的摄取和内化。在过量半乳糖存在下,Gal-C4-Chol含量为3.5%、5.0%和7.5%的Gal-脂质体的摄取受到抑制,提示去唾液酸糖蛋白受体介导的摄取。静脉注射后,Gal-C4-Chol含量为3.5%、5.0%和7.5%的Gal-脂质体迅速从血液中消失,并在10分钟内迅速在肝脏中蓄积,高达约80%的剂量,而Gal-C4-Chol含量低(1.0%和2.5%)的Gal-脂质体与空白脂质体相比,肝脏蓄积略有改善。高Gal-C4-Chol的Gal-脂质体优先被肝细胞摄取,Gal-C4-Chol含量为5.0%的Gal-脂质体在实质细胞(PC)和非实质细胞(NPC)中的摄取率最高(PC/NPC比值)。我们在此报告,由Gal-C4-Chol制备的Gal-脂质体的半乳糖密度对于去唾液酸糖蛋白受体的有效识别和细胞内化都很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验